Development of the Korean Association for Lung Cancer Clinical Practice Guidelines: Recommendations on Radial Probe Endobronchial Ultrasound for Diagnosing Lung Cancer - An Updated Meta-Analysis
Cancer Research and Treatment · 2024
DOI: 10.4143/crt.2023.749 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Research and Treatment, 2024. Verfasst von Soo Han Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea. Hauptthemen laut MEDLINE: Lung Neoplasms, Endosonography. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
Radial probe endobronchial ultrasound (RP-EBUS) accurately locates peripheral lung lesions (PLLs) during transbronchial biopsy (TBB). We performed an updated meta-analysis of the diagnostic yield of TBB for PLLs using RP-EBUS to generate recommendations for the development of the Korean Association of Lung Cancer guidelines.Materials and Methods We systematically searched MEDLINE and EMBASE (from January 2013 to December 2022), and performed a meta-analysis using R software. The diagnostic yield was evaluated by dividing the number of successful diagnoses by the total lesion number. Subgroup analysis was performed to identify related factors.
Results
Forty-one studies with a total of 13,133 PLLs were included. The pooled diagnostic yield of RP-EBUS was 0.72 (95% confidence interval [CI], 0.70 to 0.75). Significant heterogeneity was observed among studies (χ2=292.38, p < 0.01, I2=86.4%). In a subgroup analysis, there was a significant difference in diagnostic yield based on RP-EBUS findings (within, adjacent to, invisible), with a risk ratio of 1.45 (95% CI, 1.23 to 1.72) between within and adjacent to, 4.20 (95% CI, 1.89 to 9.32) between within and invisible, and 2.59 (95% CI, 1.32 to 5.01) between adjacent to and invisible. There was a significant difference in diagnostic yield based on lesion size, histologic diagnosis, computed tomography (CT) bronchus sign, lesion character, and location from the hilum. The overall complication rate of TBB with RP-EBUS was 6.8% (bleeding, 4.5%; pneumothorax, 1.4%).
Conclusion
Our study showed that TBB with RP-EBUS is an accurate diagnostic tool for PLLs with good safety profiles, especially for PLLs with within orientation on RP-EBUS or positive CT bronchus sign.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
- Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
- Division of Pulmonology, National Cancer Center, Goyang, Korea.
- Department of Biostatistics, Pusan National University Hospital, Busan, Korea.
- Department of Internal Medicine, Dong-A University Hospital, Busan, Korea.
Zitieren
APA
Kim, S. H., Chung, H. S., Kim, J., Kim, M. H., Lee, M. K., Kim, I., & Eom, J. S. (2024). Development of the Korean Association for Lung Cancer Clinical Practice Guidelines: Recommendations on Radial Probe Endobronchial Ultrasound for Diagnosing Lung Cancer - An Updated Meta-Analysis. Cancer Research and Treatment. https://doi.org/10.4143/crt.2023.749
Vancouver
Kim SH, Chung HS, Kim J, Kim MH, Lee MK, Kim I, et al. Development of the Korean Association for Lung Cancer Clinical Practice Guidelines: Recommendations on Radial Probe Endobronchial Ultrasound for Diagnosing Lung Cancer - An Updated Meta-Analysis. Cancer Research and Treatment. 2024. doi:10.4143/crt.2023.749
BibTeX
@article{Kim2024,
author = {Kim, Soo Han and Chung, Hyun Sung and Kim, Jinmi and Kim, Mi-Hyun and Lee, Min Ki and Kim, Insu and Eom, Jung Seop},
title = {Development of the Korean Association for Lung Cancer Clinical Practice Guidelines: Recommendations on Radial Probe Endobronchial Ultrasound for Diagnosing Lung Cancer - An Updated Meta-Analysis},
journal = {Cancer Research and Treatment},
year = {2024},
doi = {10.4143/crt.2023.749}
}
EUVIMED